Delcath Systems, Inc. (DCTH) Trading Down 1.8%

Delcath Systems, Inc. (NASDAQ:DCTH) traded down 1.8% during trading on Monday . The stock traded as low as $0.12 and last traded at $0.13. 19,596,040 shares were traded during mid-day trading, a decline of 80% from the average session volume of 98,822,600 shares. The stock had previously closed at $0.12.

The company’s market capitalization is $52.63 million. The company has a 50 day moving average of $0.12 and a 200-day moving average of $0.10.

An institutional investor recently raised its position in Delcath Systems stock. Virtu KCG Holdings LLC boosted its holdings in shares of Delcath Systems, Inc. (NASDAQ:DCTH) by 72.4% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,518,724 shares of the medical device company’s stock after purchasing an additional 637,689 shares during the period. Virtu KCG Holdings LLC owned about 1.28% of Delcath Systems worth $299,000 as of its most recent filing with the Securities and Exchange Commission (SEC). 7.97% of the stock is owned by institutional investors.

COPYRIGHT VIOLATION NOTICE: This piece was first reported by Stock Observer and is the sole property of of Stock Observer. If you are accessing this piece on another domain, it was stolen and reposted in violation of United States and international copyright and trademark law. The original version of this piece can be viewed at https://www.thestockobserver.com/2017/09/13/delcath-systems-inc-dcth-trading-down-1-8.html.

Delcath Systems Company Profile

Delcath Systems, Inc is a late-stage clinical development company with early commercial activity in Europe focused on cancers of the liver. The Company is a specialty pharmaceutical and medical device company developing its product, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS).

Receive News & Ratings for Delcath Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Delcath Systems Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply